James R. Meyers

President & Chief Executive Officer at IntraBio

James R. Meyers

James R. Meyers

President & Chief Executive Officer at IntraBio

Biography

Presently, James R. Meyers is President & Chief Executive Officer for IntraBio, Inc. Mr. Meyers is also on the board of 5 other companies. In the past he was Executive VP-Worldwide Commercial Operations at Gilead Sciences, Inc. Mr. Meyers received an undergraduate degree from Boston College.

Overview
Career Highlights

IntraBio

RelSci Relationships

1071

Number of Boards

7

Birthday

1965

Age

56

Contact Data
Trying to get in touch with James R. Meyers? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals James R. Meyers likely has professional access to. A relationship does not necessarily indicate a personal connection.

President, Chief Executive Officer & Chairman at CytomX Therapeutics, Inc.

Relationship likelihood: Strong

Chief Executive Officer & Chairman of the Board at Theravance Biopharma, Inc.

Relationship likelihood: Strong

President, Chief Executive Officer & Director at Nkarta, Inc.

Relationship likelihood: Strong

Director, President & Chief Executive Officer at Codexis, Inc.

Relationship likelihood: Strong

Former Interim Chief Executive Officer at Gilead Sciences, Inc.

Relationship likelihood: Strong

Director, President & Chief Executive Officer at Amyris, Inc.

Relationship likelihood: Strong

Founder at Biotechnology Innovation Organization

Relationship likelihood: Strong

Former Managing Director at Bay City Capital LLC

Relationship likelihood: Strong

Former Chief Operating Officer at Gilead Sciences, Inc.

Relationship likelihood: Strong

Member of the Enlarged Corporate Executive Committee, Global Head Pharma Partnering at Roche Holding AG

Relationship likelihood: Strong

Paths to James R. Meyers
Potential Connections via
Relationship Science
You
James R. Meyers
President & Chief Executive Officer at IntraBio
Education
Bachelor's Degree in Economics

Boston College is one of the nation's best and most selective universities, with U.S. News & World Report ranking Boston College 31st among national universities, and Forbes ranking it 26th in its 2012 America's Best Colleges listing. Boston College confers more than 4,000 degrees annually in more than 50 fields of study through eight schools and colleges. Faculty members are committed to both teaching and research having earned nearly $60 million in research grants in the last year alone. The University has made a major commitment to academic excellence. As part of its Strategic Plan, Boston College is in the process of adding 100 new faculty positions, expanding faculty and graduate research, increasing student financial aid to more than $128 million annually, and widening opportunities in key undergraduate programs, such as international study, internships and student formation. Boston College has experienced tremendous growth in recent years, including a 75 percent increase in undergraduate applications over the past decade, to more than 34,000 for the 2,250 seats in its freshman class. During the same period, an increase in voluntary giving from alumni has helped to move the University's endowment to approximately $1.9 billion. Boston College students have also earned more than 200 prestigious academic scholarships over the past decade, including 2 Rhodes Scholarships, 4 Marshalls, 9 Goldwaters and 162 Fulbright grants.

Career History
President & Chief Executive Officer
2020 - Current

IntraBio is a biopharmaceutical company.

Executive Vice President, Worldwide Commercial Operations
1996 - 2018

Since 1987, Gilead Sciences has worked to discover, develop and commercialize medications to advance the care of patients suffering from life-threatening diseases in areas of unmet medical need. In 25 years, Gilead has become a leading biopharmaceutical company with a portfolio of 15 marketed products, a growing pipeline of investigational drugs and approximately 5,000 employees in offices across four continents. Gilead's therapeutic areas of focus include HIV/AIDS, hepatitis, serious respiratory, cardiovascular, and metabolic conditions, cancer and inflammation

Boards & Committees
Director
Tenure Unconfirmed
Public Holdings
Restricted data only for RelSci Professional users.
Other Affiliations

James R. Meyers is affiliated with IntraBio, Gilead Sciences, Inc., Gilead Sciences Foundation

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by James R. Meyers. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of James R. Meyers's profile does not indicate a business or promotional relationship of any kind between RelSci and James R. Meyers.